Partnering with Patients and Caregivers in Clinical Research
One definition of patient-centricity is “Putting the patient first in an open and sustained engagement of the patient to respectfully and compassionately achieve the best…
Pharma
When and Where to use Virtual Engagement for Face-to-face Life Science Congresses
COVID-19 disrupted and redefined the structure of life science congresses – large annual meetings where HCPs and drug and device developers come together to exchange…
Getting Data in Order for a Data-driven Future
As data becomes more important than documents when it comes to regulatory submissions and operational decision-making, there is a renewed focus on data quality. Amplexor’s…
Medical Affairs Teams need to Learn to Engage with Digital Opinion Leaders
Medical affairs teams should engage opinion leaders to shape products and help them reach a target market. This engagement constitutes developing relationships with clinicians and…
Forging a New Path for Pharma in Value-based Healthcare
Pharma’s role in healthcare is changing amid the rise in more-targeted treatments and a shift in emphasis to preventative medical interventions. Gérard Klop of Vintura…
Digital Opinion Leaders (DOLs): Who are they and how can Pharma Engage Them?
With our growing dependence on social media over the past decade, Digital Opinion Leaders–or “DOLs” for short–are becoming an increasingly important stakeholder group for Pharma…
Pharma Join Together to Achieve New Standards in Digital and Patient Innovation for Clinical Transformation
On May 17th, 500+ of pharma’s clinical innovation will come together for the home of clinical collaboration, Reuters Events: Pharma Clinical 2022, to set new…
A New Model for Novel Biopharma
Novel and Advanced Therapies have made great strides over the past decade but that means that manufacturing process consistency, GMP standards and so on must…
Biotechs need to build in data management from the outset
Biopharma start-ups need to identify the best data-management processes and systems – but to do so means they need to avoid the mistakes made by…
Digital-Forward Pharma Will Outperform, if HCP Focus Stays Strong
The European Commission recently unveiled two long-awaited proposals on digital services and digital markets. While we don’t yet know how—or when—these measures will be enacted,…